Search

Bridelia micrantha is a medicinal plant used traditionally for the treatment of wounds. However, there are no documented scientific reports on the wound healing activities of this plant. This study was conducted to investigate the antimicrobial, antioxidant and wound healing activities of methanol leaf extract of B. micrantha (BME). The antimicrobial activity was determined using the agar well diffusion and broth dilution methods. Antioxidant activity was performed in vitro using the DPPH scavenging antioxidant activity followed by in vivo wound healing activities using the excision wound model. Preliminary phytochemical screening of BME showed the presence of saponins, tannins, flavonoids, alkaloids, triterpenes, glycosides, steroids and coumarins. BME exhibited dose-dependent antimicrobial activities. The most susceptible organism to BME was N. gonorrhoeae with mean zones of inhibition ranging from 20.50 ± 1.00 to 28.50 ± 1.00 mm. The least susceptible organism was S. typhi with mean zones of inhibition in the range of 15.50 ± 0.00 to 21.50 ± 0.00 mm. The MICs of BME against the test organisms were in the range of 1.25 to 2.5 mg/mL. Sub-inhibitory concentrations of BME potentiated the activities of ciprofloxacin and ketoconazole. BME showed a dose-dependent increase in antioxidant activity with IC50 of 0.2626 µg/mL. The BME formulated creams at concentrations of 0.625, 2.5, and 10% w/w showed a significant (p

Introduction People living with HIV/AIDS (PLHIV) widely use medicinal plants for boosting immunity and managing infections. The aim of this study was to document the medicinal plant species used by herbalists to boost the immune system of people living with HIV/AIDS in Uganda. Methods Semi-structured questionnaires were administered to 90 herbalists to obtain ethnobotanical information on medicinal plant species used in different parts of Uganda. A detailed literature review of the pharmacology, phytochemistry, toxicology and other traditional used of the documented medicinal plants was also conducted. Results Seventy-one medicinal plant species from 37 families and 64 genera were identified. Trees contributed 38.0 % of the species used and herbs 35.2 %. The majority of the herbal medicines were made from leaves (35.6 %), bark (24.1 %) and roots (20.7 %). Zanthoxylum chalybeum Engl. and Psidium guajava L. were the most widely used species with citation frequencies (CF) of 11 each. These were followed by Warburgia ugandensis Sprague, Acacia hockii De Wild. and Bridelia micrantha (Hochst.) Baill (CF = 8 each), Mangifera indica L., Markhamia lutea (Benth.) K. Schum., Aloe vera (L.) Burm.f. and Erythrina abyssinica DC. (CF = 7 each). Most traditional medicine practitioners (TMP) (85.6%) used herbs for boosting immunity for PLHIV, whether or not the patients were on antiretroviral treatment. The patients often disclosed their sero-status to the TMP who considered all PLHIV to be immunocompromised. Conclusion Herbalists widely prescribe medicinal plant species for boosting or restoring the immunity in PLHIV in Uganda.

Bridelia micrantha is traditionally used in tropical Africa to treat a wide range of human and animal diseases. The aim of this study was to summarise the research that has been done on the ethnomedicinal uses, phytochemistry and pharmacological properties of B. micrantha so as to understand its importance and potential value in primary healthcare systems. The literature search for information on ethnomedicinal uses and pharmacological activities of B. micrantha was undertaken using databases such as Web of Science, Scopus, Google Scholar, Science Direct, BioMed Central (BMC), PubMed and Springerlink. Other relevant literature sources included books, book chapters, websites, theses, conference papers and other scientific publications. This study showed that B. micrantha is used as herbal medicine in just over half (57.3%) of the countries in tropical Africa where it is indigenous. A total of 54 ethnomedicinal uses of B. micrantha have been recorded with a high degree of consensus on burns, wounds, conjunctivitis, painful eyes, constipation, gastric ulcers, cough, headache, rheumatism, painful joints, dysentery, ethnoveterinary medicine, malaria, sexually transmitted infections, stomach ache, tape worms and diarrhoea. Different plant parts, aqueous and organic extracts exhibited anthelmintic, antimicrobial, anticonvulsant and sedative, antidiabetic, antidiarrhoeal, antinociceptive, antioxidant, antiplasmodial, antischistosomal, hepatoprotective, insecticidal and β-lactamase inhibitory activities.

Schistosomiasis in humans is a major public health problem worldwide. Schistosomiasis occurs in 76 tropical countries and it is estimated that 85% of the infections are in Africa. In Kenya, it is estimated that 3 million people are infected. The Conventional drugs are effective in the treatment of the disease but very little progress has been achieved on treatment of Schistosomiasis in Kenya. Any effort towards developing alternative drugs for the disease is worthwhile. Praziquantel is the most effective drug against all adult stages of human Schistosomiasis, being the drug of choice for morbidity control of Schistosomiasis. However it is not a satisfying situation to have one drug used for the treatment. Ideally other drugs should be availed in order to avoid development of drug resistance. The use of plant extracts in treatment of diseases is universal. The results obtained showed that Ocimum americanum and Bridelia micrantha plant extracts had antischistosomal activity as indicated by high worm reduction and reduced gross pathology. Histopathology showed no or few granuloma in the liver tissue. Further work should be done on the efficacious extracts, towards drug development.

Background-The T helper 1 (TH1) and TH2 dichotomy was first shown in murine CD4+ lymphocytes clones and these cells could be differentiated in terms of the cytokines they secrete. The TH1 subsets produce interleukin 2 (IL-2,) interferon gamma (IFN-γ) and lymphotoxin, TH2 subsets produce IL-4, IL-5, IL-6 IL-10 and IL-13. An important function of the TH2 response during infection is to produce cytokines that can prevent or dampen the production or effector functions of potentially dangerous inflammatory mediators. Results The results obtained showed that Ocimum americanum hexane (OAH) and Bridelia micrantha (BMW) water extract had antischistosomal activity. This was indicated by low worm recovery, high worm reduction, and reduced gross pathology with histopathology showing no or few granulomas in the liver tissue, which was similar to Praziquantel (PZQ). The two extracts had both cellular and humoral responses as demonstrated by IFN-γ, IL-5 and IgG responses. OAH and BMW were significantly similar to PZQ; however BMW had higher IgG responses. BMW had higher IFN-γ responses for both spleen and lymph node cells. Conclusion this implied that treatment groups were able to produce the TH-1 response which is important for cell mediated immunity. Although both extracts induced production of IL-5 for both lymph node and spleen cells, OAH generated more IL-5.

Insect pest infestation is a major factor militating against okra production and farmers generally adopt synthetic insecticides for its management. A field trial was undertaken to evaluate the insecticidal potency of Bridelia micrantha and Dalbergia lactea for the management of Podagrica uniforma (Jacoby) and Nisotra dilecta (Jacoby) insect pest of okra ( Abelmoschus esculentus L. Moench). The treatments consisted of aqueous leaf extracts of Bridelia micrantha and Dalbergia lactea and Cypermethrin as check; laid out in Randomized Complete Block Design and repli-cated three times. Data was collected on insect population before treatment application and 3 days after spraying of insecticides at 28, 35, 42, 56 days after planting (DAP). Yield parameters data collected were number of fruits and fruit weight. Results obtained showed that the plant extracts exhibited effectiveness in reducing the insect population and improved okra fruit yield compared to Cypermethrin. The order of effectiveness in decreasing sequence was found to be Cypermethrin ˃ D. lacteal ˃ B. micrantha . D. lacteal and B. micrantha crude extracts could be explored as promising insecticidal agents to provide valuable alternatives to chemical control of insect infestation on okra. Further study is recommended to determine the chemical constituents responsible for the plant insecticidal activity.

Bridelia micrantha and Croton macrostachyus are medicinal plants used empirically in traditional medicine to treat epilepsy. In vivo mice model (maximal electroshock, strychnine, pentylenetetrazol, picrotoxin, isonicotinic hydrazide acid)-induced convulsions were used to evaluate the anticonvulsant activities of those plants. Diazepam-induced sleep was used for the evaluation of the sedative properties. B. micrantha protected 100, 80, 80, and 80% of mice against PIC, STR, PTZ and MES-induced seizures, respectively. C. macrostachyus at the doses 34 and 67 mg/kg protected 80, 80, 80 and 60% of mice from PIC, STR, PTZ and MES-induced seizures, respectively. B. micrantha and C. macrostachyus also delayed the onset to seizures in INH test. B. micrantha was more potent than C. macrostachyus in protecting mice against convulsions. The co-administration of the sub effective dose of the decoction of B. micrantha or C. macrostachyus with the sub effective dose of diazepam or clonazepam resulted in a synergistic effect. The decoctions of B. micrantha and C. macrostachyus also exerted sedative activity by increasing the total duration of sleep induced by diazepam and by reducing the latency time to sleep. The effect of the decoctions of B. micrantha and C. macrostachyus suggests the presence of anticonvulsant activities that might show efficacy against secondarily generalized tonic-clonic seizures and primary generalized seizures in humans.

Helicobacter pylori is a major risk factor for gastritis, ulcers and gastric cancer. This study was aimed to determine the antimicrobial activity of the stem bark of Bridelia. micrantha on H. pylori isolated in South Africa. Extracts and clarithromycin were tested against 31 clinical strains, including a standard strain (NCTC 11638) of H. pylori, by measuring the diameters of the corresponding inhibition zones, followed by determination of the Minimum Inhibitory Concentration (MIC) (using metronidazole, and amoxicillin as control antibiotics) and the rate of kill. Preliminary phytochemical screening was also done. Inhibition zone diameters which ranged from 0–23 mm were observed for all five of the extracts and 0–35 mm for clarithromycin. Marked susceptibility of strains (100%) was noted for the acetone extract (P < 0.05), followed by ethyl acetate extract (93.5%). The MIC50 values ranged from 0.0048 to 0.156 mg/mL for the ethyl acetate extract and 0.0048 to 0.313 mg/mL for the acetone extract. The MIC90 values ranged from 0.0048 to 2.5 mg/mL for the ethyl acetate extract and 0.078 to >0.625 mg/mL for the acetone extract, respectively. Insignificant statistical difference in potency was observed when comparing the crude ethyl acetate extract to metronidazole and amoxicillin (P > 0.05). Complete killing of strain PE430C by the ethyl acetate extract was observed at 0.1 mg/mL (2 × MIC) and 0.2 mg/mL (4 × MIC) at 66 and 72 h. For strain PE369C, 100% killing was observed at 0.1 mg/mL (2 × MIC) in 66 and 72 h. The ethyl acetate extract could thus be a potential source of lead molecules for the design of new anti-Helicobacter pylori therapies as this study further confirmed the presence of phytochemicals including alkaloids, flavonoids, steroids, tannins and saponins.

Bridelia micrantha (Hochst) Baill. (Euphorbiaceae), commonly known in English as “coast gold leaf” or “ogaofia” (the boss of the bush) in Igbo, is a semi-deciduous to deciduous tree up to 20 m tall with a dense rounded crown and tall, and bare stem indigenous to southern part of Nigeria. Its stem bark, which is yellow grey and smooth to slightly rough, has been of interest to researchers because of its use in the treatment of various disease conditions in Nigerian traditional medicine. The present study was targeted at investigating the antidiabetic and antioxidant effects of the methanol extract of B. micrantha leaves using alloxan-induced diabetic mice in vivo and in vitro. The extract, at the dose of 250, 500, and 1,500 mg/kg, showed a remarkable time-dependent decrease in blood glucose level in alloxan-induced diabetic mice. There was no significant difference between the extract-treated groups and the groups treated with 10 mg/kg distilled water and glibenclamide (2 mg/kg), respectively. Six hours posttreatment, the blood glucose level for the groups treated with 250 mg/kg of B. micrantha and glibenclamide (2 mg/kg), respectively, were lower than the normal blood glucose level respectively for the groups before the induction of diabetes. B. micrantha showed its optimum antioxidant activity in DPPH spectrophotometric assay at the concentration of 400 μg/ml. The ferric reducing antioxidant power showed a significant concentration-dependent increase in the total antioxidant power. These findings demonstrate that B. micrantha has both antidiabetic and antioxidant effects on experimental model of diabetes in mice and validate its use in Nigerian traditional medicine for the treatment of diabetes. Even in its crude form, the effects were comparable to that of glibenclamide, an oral sulfonylurea with proven antidiabetic activity. This finding suggests that the extract could be a potential source of a novel antidiabetic and antioxidant agent for the management of diabetes mellitus.

Ethnopharmacological relevance Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB) is the most commonly notified disease and the fifth largest cause of mortality. One in 10 cases is resistant to treatment in some areas. Several plants are used locally to treat TB-related disease. Aims of the study The aim was to screen selected South African medicinal plants used to treat TB and related symptoms by traditional healers for antimycobacterial activity. Materials and methods Ethnobotanical information on these plants was obtained. Crude acetone, methanol, hexane and ethanol extracts of 21 selected medicinal plants obtained in Venda, South Africa were screened for their ability to inhibit MTB H 37 Ra and a clinical strain resistant to first-line drugs and one second-line drug using tetrazolium microplate assay to determine the minimum inhibitory concentration (MIC). Results were analyzed using Microsoft Excel 2007 and One way ANOVA; p Results Few acetone extracts were active against MTB with MIC under 100 μg/mL. Four plants showed lower MIC values; Berchemia discolor Klotzsch Hemsl 12, 5 μg/mL on H 37 Ra and 10.5 μg/mL on the clinical isolate, Bridelia micrantha Hochst. Baill (25 μg/mL), Warbugia salutaris Bertol. F Chiov (25 μg/mL), and Terminalia sericea Burch ex D. F (25 μg/mL) on both H 37 Ra and clinical isolate. However, the roots of Ximenia caffra Sond. Var. caffra, barks of Sclerocarya birrea (A Rich) Hochst, Asclepias fruticosa L, tubers of Allium sativum L, leaves of Carica papaya L, Solanum panduriforme E. Mey C, and roots of Securidaca longepedunculata Fresen gave MIC greater than 100 μg/mL. Conclusion The acetone extracts of Berchemia discolor , Bridelia micrantha , Terminalia sericea and Warbugia salutaris could be important sources of mycobactericidal compounds against multidrug-resistant MTB.

Aim of study This study screened for anthelmintic activity of plant species traditionally used in the treatment of intestinal parasites and their symptoms in Sub-Saharan Africa in an effort to confirm their local use and aid in the search for new compounds since resistance is a growing concern. Materials and methods Aqueous and organic extracts of 33 plant parts from 17 plant species traditionally used in the treatment of intestinal infections in Sub-Saharan Africa were evaluated for their anthelmintic activity. This activity was assessed using a standard motility assay against a levamisole resistant strain of the nematode Caenorhabditis elegans. Results and conclusions Anthelmintic activity was confirmed in 12 plant species. Of these, eight showed strong evidence of activity (p

BACKGROUND Ethnopharmacological practitioners in Nigeria have used aqueous and ethanol extracts of Bridelia micrantha leaves to manage conditions associated with inflammation, and these include diabetes, chest pain, edema, arthritis and joint pains. This study aimed to evaluate the effects of methanol leaf extract of B. micrantha on chronic inflammation and oxidative stress which accompany diabetic conditions, in streptozotocin-induced diabetic Albino Wistar rats. METHODS The dried leaves were extracted by percolation in 80% methanol:water for 72 h after which the mixture was filtered using Whatman No. 1 (11 μm) filter papers. Acute toxicity studies were done using Wistar rats and given orally up to a dose of 2,000 mg/kg. The animals were monitored for 48 h. The experimental design involved five (5) groups of six (6) albino Wistar diabetic rats each. Groups A, B and C rats received 100, 200 and 400 mg/kg B. micrantha respectively while groups D (negative control) and E (positive control) rats received 10 mL/kg normal saline and 200 mg/kg acetylsalicylic acid (ASA) respectively by gastric gavage for 7 days. Two sterilized cotton pellets (10 mg each) were implanted subcutaneously into both sides of the dorsal area of each diabetic rat in all the groups. Post cotton pellet implantation, rats in three groups (A, B and C) were treated with 100, 200 and 400 mg/kg B. micrantha extract, while those in two groups (D and E) were treated with acetyl salicylic acid (ASA 200 mg/kg) and normal saline (10 mL/kg) respectively by gastric gavage for 7 days. Serum obtained from the animals on Day 8 of the cotton pellet test were used for malondialdehyde (MDA), catalase, superoxide dismutase (SOD) and glutathione (GSH) assays. RESULTS The administration of the leaf extract up to a dose of 2,000 mg/kg to rats produced absolutely no death or observable signs of toxicity in 48 h. The cotton pellet granuloma weights in 200 mg/kg (44.88±1.2 mg), 400 mg/kg (42.10±1.2 mg) B. micrantha extract treated groups and ASA at 200 mg/kg (43.25±1.8 mg) were significantly lower compared to weight of granuloma (85.50±3.2 mg) obtained in the group treated with normal saline. Serum malondialdehyde (MDA) level in the 200 mg/kg (3.32±0.72 nmol/mL) and 400 mg/kg (1.88±1.27 nmol/mL) B. micrantha extract treated groups were significantly (p

Tanzania has over 12,000 plant species, some of which are endemic and have potential to yield useful medicines. This study seeks to document such plants used as traditional medicines for treatment of malaria in Kagera region of northwestern Tanzania and Lindi region in south eastern Tanzania. The study also reports on the antiplasmodial activity against chloroquine-resistant Plasmodium falciparum (Dd2) strain of some of the documented plants using the parasite lactate dehydrogenase method. A total of 108 plant species, among which the families Compositae (14; 12.96%), Fabaceae (12; 11.11%), Euphorbiaceae (8; 7.41%), Melastomataceae (6; 5.56%) and Myrtaceae (4; 3.70%) were documented. Sixteen (16; 44.4%) of 36 extracts from 31 plant species that were tested inhibited malaria parasites growth by more than 50%. Bersema abyssinica stem bark extract was the most active with 86.67% inhibition rate followed by Bridelia micrantha stem bark extract with 71.87% inhibition rate. These results confirm the potential for plants used in traditional medicine to yield active antimalarial compounds. Further in vitro and in vivo screening supported by bioassay-guided isolation of active compounds from plants showing good safety margin is suggested. Key words: Ethnobotanical survey, medicinal plants, malaria, treatment, in vitro antiplasmodial, Tanzania.

ObjectiveTo explore the hepatoprotective and anti-oxidant activities of the methanolic leaf extract of Bridelia micrantha (B. micrantha) on paracetamol induced liver damage in Wistar rats.MethodsParameters were measured including alanine aminotransaminase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), bilirubin and total protein. The anti-oxidant effects were studied using the 1, 1-Diphenynl-2-Picrylhydrazyl (DPPH) and Ferric Reducing Antioxidant Power (FRAP) assay methods.ResultsB. micrantha extract decreased the level of AST in the rats given PCM from (129.47±0.92I) IU/L to (57.78±1.71) IU/L (P

The methanolic leaf extract of Bridelia micrantha was tested for subacute antidiabetic and in vivo antioxidant effects in alloxan-induced hyperglycaemic rats. The subacute treatment of the extract (125, 250 and 500 mg/kg) produced 75, 68 and 63% reduction in fasting blood sugar level respectively, on day 14 of treatment. The extract produced time-dependent effect, but did not show a dose-dependent effect. Its optimum antidiabetic activity was noted at the dose of 125 mg/kg and this was comparable to glibenclamide 2 mg/kg (positive control). The extract (125 mg/kg) showed good oral glucose tolerance test (OGTT) effect in both normoglycaemic and hyperglycaemic rats. The OGTT effect of the extract (125 mg/kg) did not differ significantly (p>0.05) from glibenclamide (2 mg/kg). The antioxidant effect of the extract was assayed through the determination of the level of thiobarbituric acid reactive substance (TBARS) and catalase activity. The extract produced a dose-dependent decrease in the serum level of TBARS and gave its optimum catalase activity at the dose of 500 mg/kg. This study suggests that the B. micrantha extract has antihyperglycaemic and antioxidant activities. Therefore, could be a potential source of novel antidiabetic and antioxidant agent for the management of diabetes mellitus.

Background: Bridelia micrantha, Chenopodium ambrosoides and Ocimum americanum plant species are commonly used in traditional medicine for a number of ailments. The extracts of these plants have been shown to have anti-schistosomal activity suggesting that they could be used for the development of new chemical entities (NCEs) for the treatment of schistosomiasis. However there is limited knowledge on their toxicological profile and their use in traditional medicine may not be a satisfactory safety indication. Methods: In this study the extracts were first screened for bioactivity using brine shrimp lethality test for the determination of LC50 followed by rodent acute toxicity and 28 day subchronic studies. Results: B. micrantha water extract with a LC50 of 77µg/ml was deemed toxic while C. ambrosoides methanol and water extracts were moderately toxic with LC50 of 104.63µg/ml and 696.44µg/ml respectively. O. americanum hexane and water extracts toxicity varied from moderate to slightly toxic with LC50 of 887.59µg/ml and 2254.60µg/ml respectively. C. ambrosoides and O. americanum water extracts which were preferentially selected for subsequent studies were found to have mild to no irritation to rodent eyes and skin. Moreover, the aminotransferases AST and ALT which were used to detect liver injury suggested negligible effect. Conclusions: This therefore confirms that C. ambrosoides and O. americanum water extracts are safe for clinical use with O. americanum water extract having a slight edge.

The anti-diabetic activity of extracts and fractions from leaves of Bridelia micrantha was investigated in alloxan diabetic rats. Powdered leaves of B. micrantha were macerated with 80% MeOH for five days. The petroleum ether, CHCl3 and MeOH/H20 soluble portions were prepared from the crude aqueous MeOH extract and tested on the diabetic rats. Hyperglycaemia was induced by intraperitoneal injection of alloxan monohydrate (80mg/kg) and blood glucose monitored for seven days using a glucometer. The MeOH/H2O residue exhibited significant (p

Background Tuberculosis, caused by Mycobacterium tuberculosis (MTB), is the most notified disease in the world. Development of resistance to first line drugs by MTB is a public health concern. As a result, there is the search for new and novel sources of antimycobacterial drugs for example from medicinal plants. In this study we determined the in vitro antimycobacterial activity of n-Hexane sub-fraction from Bridelia micrantha (Berth) against MTB H37Ra and a clinical isolate resistant to all five first-line antituberculosis drugs. Methods The antimycobacterial activity of the n-Hexane sub-fraction of ethyl acetate fractions from acetone extracts of B. micrantha barks was evaluated using the resazurin microplate assay against two MTB isolates. Bioassay-guided fractionation of the ethyl acetate fraction was performed using 100% n-Hexane and Chloroform/Methanol (99:1) as solvents in order of increasing polarity by column chromatography and Resazurin microtiter plate assay for susceptibility tests. Results The n-Hexane fraction showed 20% inhibition of MTB H37Ra and almost 35% inhibition of an MTB isolate resistant to all first-line drugs at 10 μg/mL. GC/MS analysis of the fraction resulted in the identification of twenty-four constituents representing 60.5% of the fraction. Some of the 24 compounds detected included Benzene, 1.3-bis (3-phenoxyphenoxy (13.51%), 2-pinen-4-one (10.03%), N(b)-benzyl-14-(carboxymethyl) (6.35%) and the least detected compound was linalool (0.2%). Conclusions The results show that the n- Hexane fraction of B. micrantha has antimycobacterial activity.

Dichloromethane and/or ethanol extracts of 30 plants used as traditional medicines in Bukoba district, northwestern Tanzania were evaluated for brine shrimp toxicity. Among the 50 extracts tested, 32 extracts (64%) showed very low toxicity with LC50 values above 100 microg/ml. Among these 12 (24%) which had LC50 >500 microg/ml can be categorized as being practically non-toxic. Among the remaining extracts 19 (38%) which showed LC50 > 100 < 500 microg/ml are also considered to be non-toxic. Extracts that showed LC50 results between 30-100 microg/ml have been categorized as mildly toxic; these include ethanol extracts of Lantana trifolia (LC50 32.3 microg/ml), Vernonia bradycalyx (LC50 33.9 microg/ml), Antiaris toxicaria (LC50 38.2 microg/ml) and Rubus rigidus (LC50 41.7 microg/ml) and the dichloromethane extracts of Gynura scandens (LC50 36.5 microg/ml) and Bridelia micrantha (LC50 32.0 microg/ml). The dichloromethane extracts of Picralima nitida (LC50 18.3 microg/ml) and Rubus rigidus (LC50 19.8 microg/ml), were only moderately toxic. Picralima nitida and Rubus rigidus extracts are only 1.1 and 1.2 less toxic than the standard drug, cyclophosphamide (LC50 16.3 microg/ml). In conclusion, the results indicate that among the 30 plants used as traditional medicines, 28 are safe for short term use. Picralima nitida and Rubus rigidus extracts are mildly toxic, but by comparison have a remote possibility to yield active anticancer compounds.